Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith Bonnelye

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Biological Chemistry|January 17, 2014
Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activityMarion David, Irma Machuca-Gayet, Junichi Kikuta, et al.
Communications Biology|January 18, 2020
The matrix vesicle cargo miR-125b accumulates in the bone matrix, inhibiting bone resorption in miceTomoko Minamizaki, Yuko Nakao, Yasumasa Irie, et al.
Calcified Tissue International|March 27, 2025
Bone Effects of Anti-Cancer Treatments in 2024Marie Teissonnière, Mathieu Point, Emmanuel Biver, et al.
Oncogene|January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesionsFrancesco Pantano, Martine Croset, Keltouma Driouch, et al.
Cancer Research|May 6, 2020
ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune ResponseMathilde Bouchet, Alexandra Lainé, Cyril Boyault, et al.
Calcified Tissue International|June 20, 2018
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone MetastasisEvelyne Gineyts, Nicolas Bonnet, Cindy Bertholon, et al.
Oncotarget|October 25, 2016
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in boneAnais Fradet, Mathilde Bouchet, Carine Delliaux, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Biological Chemistry|January 17, 2014
Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activityMarion David, Irma Machuca-Gayet, Junichi Kikuta, et al.
Communications Biology|January 18, 2020
The matrix vesicle cargo miR-125b accumulates in the bone matrix, inhibiting bone resorption in miceTomoko Minamizaki, Yuko Nakao, Yasumasa Irie, et al.
Calcified Tissue International|March 27, 2025
Bone Effects of Anti-Cancer Treatments in 2024Marie Teissonnière, Mathieu Point, Emmanuel Biver, et al.
Oncogene|January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesionsFrancesco Pantano, Martine Croset, Keltouma Driouch, et al.
Cancer Research|May 6, 2020
ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune ResponseMathilde Bouchet, Alexandra Lainé, Cyril Boyault, et al.
Calcified Tissue International|June 20, 2018
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone MetastasisEvelyne Gineyts, Nicolas Bonnet, Cindy Bertholon, et al.
Oncotarget|October 25, 2016
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in boneAnais Fradet, Mathilde Bouchet, Carine Delliaux, et al.
Pageof 4